Status:
COMPLETED
Effect of Liver Injury on Mortality in Coronavirus Disease-2019 Patients Admitted to Intensive Care Unit
Lead Sponsor:
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Conditions:
Covid19; Liver Injury; Mortality
Eligibility:
All Genders
18+ years
Brief Summary
In addition to primarily affecting the lungs, coronavirus disease-2019 (COVID-19) disease can also affect many different organs, especially the heart, kidneys, liver and brain. In this group of patien...
Eligibility Criteria
Inclusion
- Patients diagnosed with COVID-19 on the specified dates, followed in the ICU, older than 18 years, identified as critical/serious according to the World Health Organization and provisional guidelines of the Scientific Board of the T.R. Ministry of Health will be included in the study.
Exclusion
- ICU patients without COVID-19, COVID-19 patients under 18 years of age,COVID-19 patients with known liver disease, and COVID-19 patients with mild to moderate symptoms will be excluded from the study.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 14 2020
Estimated Enrollment :
532 Patients enrolled
Trial Details
Trial ID
NCT04669509
Start Date
April 1 2020
End Date
December 14 2020
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Diyarbakır, Turkey (Türkiye)